BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 8740018)

  • 1. Postchemotherapy surgery in nonseminomatous testicular tumors.
    Hornák M; Ondrus D; Matoska J; Cársky S
    Eur Urol; 1996; 29(3):325-30. PubMed ID: 8740018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neo-adjuvant chemotherapy with delayed orchiectomy in patients with advanced germ cell testicular cancer.
    Ondrus D; Hornák M; Matoska J
    Neoplasma; 1993; 40(3):189-92. PubMed ID: 7688871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resection of residual pulmonary masses after chemotherapy in patients with metastatic non-seminomatous germ cell tumours.
    Horvath LG; McCaughan BC; Stockle M; Boyer MJ
    Intern Med J; 2002 Mar; 32(3):79-83. PubMed ID: 11885847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of chemotherapy and salvage surgery for advanced testicular cancer].
    Saiki S; Meguro N; Maeda O; Kinouchi T; Kuroda M; Usami M; Kotake T; Miki T
    Hinyokika Kiyo; 1999 Nov; 45(11):777-81. PubMed ID: 10637743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
    Besse B; Grunenwald D; Fléchon A; Caty A; Chevreau C; Culine S; Théodore C; Fizazi K
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):448-52. PubMed ID: 19185168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer.
    Rick O; Bokemeyer C; Weinknecht S; Schirren J; Pottek T; Hartmann JT; Braun T; Rachud B; Weissbach L; Hartmann M; Siegert W; Beyer J
    J Clin Oncol; 2004 Sep; 22(18):3713-9. PubMed ID: 15365067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological outcome of delayed orchidectomy after primary chemotherapy for metastatic germ cell tumour of the testis.
    Ramani VA; Grey BR; Addla SK; Dunham MP; Sangar VK; Clarke NW
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):247-52. PubMed ID: 18093814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of testicular cancer: 10-year experience.
    Ondrus D; Hornák M; Matoska J; Kausitz J; Belan V; Cársky S
    Neoplasma; 1993; 40(4):247-53. PubMed ID: 7505886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of salvage surgery following chemotherapy in advanced testicular cancer].
    Miki T; Saki S; Kotake T
    Hinyokika Kiyo; 1994 Oct; 40(10):951-5. PubMed ID: 7992713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone.
    Coogan CL; Foster RS; Rowland RG; Bihrle R; Smith ER; Einhorn LH; Roth BJ; Donohue JP
    Urology; 1997 Dec; 50(6):957-62. PubMed ID: 9426730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
    Beck SD; Foster RS; Bihrle R; Donohue JP; Einhorn LH
    Cancer; 2007 Sep; 110(6):1235-40. PubMed ID: 17665498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experiences in the treatment of advanced nonseminomatous testicular tumor].
    Scheiber K; Salzer M; Bartsch G
    Wien Klin Wochenschr; 1986 Aug; 98(15):481-6. PubMed ID: 2429460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumors.
    Kesler KA; Rieger KM; Hammoud ZT; Kruter LE; Perkins SM; Turrentine MW; Schneider BP; Einhorn LH; Brown JW
    Ann Thorac Surg; 2008 Feb; 85(2):371-8. PubMed ID: 18222228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P; Haas RJ; Göbel U; Calaminus G
    Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
    Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
    Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PVB therapy for advanced testicular cancer].
    Nakao M; Nakagawa S; Toyoda K; Nukui M; Takada H; Ebisui K; Sugimoto K; Watanabe H; Maegawa M; Miyakoda K
    Hinyokika Kiyo; 1989 Nov; 35(11):1871-5. PubMed ID: 2482672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.